EveryAILaw.com

Section 6-1-1702 applies when a developer creates covered ADMT intended, documented, marketed, advertised, configured, or contracted to make consequential decisions, or becomes aware it is being used to make such decisions consistently with its intended and contracted uses (§ 6-1-1702(5)). The subsection (1)-(2) disclosure duties apply only where the ADMT was marketed, advertised, configured, contracted, sold, or licensed to materially influence a consequential decision (§ 6-1-1702(3)). The definitions and exclusions for consequential decisions and covered ADMT still apply (§ 6-1-1701(3), (5)). Section 6-1-1708 provides sector qualifications. Qualifying insurers and affiliates are deemed compliant in the practice of insurance, but employment decisions remain covered. The HIPAA exclusion covers a covered entity doing business in Colorado and its business associates for services rendered to that covered entity, with an exception for employment and employment-opportunity decisions; for healthcare providers the subsection (3) treatment applies only when operating from a Colorado location. FDA-supervised medical devices and specified pharmaceutical or medical-device research and development activities are also excluded (§ 6-1-1708(1)-(4)).